Total Payments
$4,329
2024 Payments
$1,132
Companies
11
Transactions
71
Payment Breakdown by Category
Food & Beverage$4,314 (99.7%)
Education$15.06 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,314 | 70 | 99.7% |
| Education | $15.06 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $987.76 | 15 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $878.71 | 8 | $0 (2024) |
| ABBVIE INC. | $744.94 | 23 | $0 (2024) |
| ITI, Inc. | $480.66 | 7 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $459.33 | 8 | $0 (2024) |
| Allergan Inc. | $216.48 | 3 | $0 (2018) |
| Alkermes, Inc. | $195.29 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $134.24 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $122.06 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $94.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,132 | 23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($459.33) |
| 2023 | $760.87 | 18 | ABBVIE INC. ($380.17) |
| 2022 | $265.53 | 3 | ITI, Inc. ($250.47) |
| 2020 | $69.19 | 1 | ITI, Inc. ($69.19) |
| 2019 | $566.55 | 5 | Otsuka America Pharmaceutical, Inc. ($338.90) |
| 2018 | $797.52 | 11 | Sunovion Pharmaceuticals Inc. ($351.16) |
| 2017 | $737.30 | 10 | Sunovion Pharmaceuticals Inc. ($408.95) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Neuropsychiatry | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $94.20 | General |
| Category: Neuroscience | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $115.41 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $96.26 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $117.92 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $97.65 | General |
| Category: CNS | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: CNS | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Robert Goodwin, M.D
Dr. Robert Goodwin, M.D is a Specialist healthcare provider based in South Windsor, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215051164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Goodwin, M.D has received a total of $4,329 in payments from pharmaceutical and medical device companies, with $1,132 received in 2024. These payments were reported across 71 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($4,314).
Ad
Practice Information
- Specialty Specialist
- Other Specialties Psychiatry
- Location South Windsor, CT
- Active Since 03/18/2007
- Last Updated 10/31/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215051164
Products in Payments
- LATUDA (Drug) $987.76
- VRAYLAR (Drug) $961.42
- CAPLYTA (Drug) $939.99
- REXULTI (Drug) $878.71
- LYBALVI (Drug) $195.29
- INGREZZA (Drug) $134.24
- Austedo XR (Drug) $122.06
- INVEGA SUSTENNA (Drug) $94.20
- TRINTELLIX (Drug) $15.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.